EYLEA 40 mg/mL (aflibercept solution for intravitreal injection) - Important Safety Information from Bayer Ltd as approved by the HPRA

Notice type: 3rd Party Publications

Date: 16/04/2021

Important Safety Information from Bayer Ltd regarding EYLEA 40 mg/mL (aflibercept solution for intravitreal injection): Higher risk of intraocular pressure increase with the pre-filled syringe